Kenneth Merck, APRN
Family · Clemson, SCNPI 1740898337
Payments from drug & device makers
Across 141 payments — averaging $13.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$270
- Axsome Therapeutics, Inc.$246
- ANI Pharmaceuticals, Inc.$184
- United Therapeutics Corporation$181
- Actelion Pharmaceuticals US, Inc.$172
- Inspire Medical Systems, Inc.$115
- plus $803 from 17 others
What the payments were for
- Food & beverage$1,972100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 32 | $270 |
| Axsome Therapeutics, Inc. | 39 | $246 |
| ANI Pharmaceuticals, Inc. | 6 | $184 |
| United Therapeutics Corporation | 9 | $181 |
| Actelion Pharmaceuticals US, Inc. | 8 | $172 |
| Inspire Medical Systems, Inc. | 6 | $115 |
| Boehringer Ingelheim | 6 | $107 |
| AstraZeneca(2 entities) | 6 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Mallinckrodt Hospital Products Inc. | 2 | $67 |
| GSK | 4 | $63 |
| Sanofi | 2 | $59 |
| Genentech USA, Inc. | 2 | $52 |
| Harmony Biosciences LLC | 2 | $36 |
| Amgen | 2 | $28 |
| Idorsia Pharmaceuticals US Inc | 2 | $27 |
| Bayer | 1 | $22 |
| Mylan Specialty L.p. | 1 | $20 |
| Edwards Lifesciences | 1 | $19 |
| Resmed Corp | 1 | $14 |
| Boston Scientific | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $13 |
How this compares
$1,972 in reported general payments places this provider in the 75th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Modafinil | 17 | $465 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $399 |
| Zaleplon | 19 | $343 |
| Gabapentin | 40 | $294 |
| Doxepin Hcl | 22 | $239 |
| Trazodone Hcl | 94 | $203 |
| Zolpidem Tartrate | 27 | $196 |
| Temazepam | 27 | $178 |
| Clonazepam | 59 | $171 |
| Ropinirole Hcl | 14 | $150 |
| Eszopiclone | 24 | $128 |
| Paroxetine Hcl | 13 | $81 |
| Methylphenidate Hcl | 16 | $81 |
Paid to pharmacies, not to this prescriber.
Other family in Clemson
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.